Insider Shareholders with Direct Ownership of Apellis Pharmaceuticals, Inc. (APLS)
This section provides a comprehensive overview of the insiders with direct ownership of Apellis Pharmaceuticals, Inc. (APLS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Apellis Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Morningside Venture Investments Ltd
> 10% Shareholder |
250,000 | 0 | 12,806,342 $377 Million | 1 |
Nov 18, 2021
Added 1.91%
|
|
Cormorant Asset Management, Lp
> 10% Shareholder |
3,473,925 | 0 | 3,473,925 $102 Million | 1 |
Nov 13, 2017
Added 23.57%
|
|
Pascal Deschatelets
Chief Scientific Officer |
778,854 | 487,538 | 1,147,716 $33.8 Million | 79 |
Jan 29, 2025
Reduced 0.07%
|
|
Cedric Francois
Chief Executive Officer |
1,527,151 | 1,819,535 | 415,695 $12.3 Million | 51 |
Jan 29, 2025
Reduced 0.67%
|
|
Alec Machiels
Director |
190,234 | 72,750 | 377,028 $11.1 Million | 82 |
Jan 01, 2025
Added 1.64%
|
|
A. Sinclair Dunlop
Director |
170,287 | 11,894 | 158,393 $4.67 Million | 23 |
Jan 01, 2025
Added 3.81%
|
|
David O. Watson
General Counsel |
272,840 | 171,945 | 144,299 $4.25 Million | 45 |
Jan 29, 2025
Reduced 0.48%
|
|
Timothy Eugene Sullivan
Chief Financial Officer |
302,577 | 197,781 | 128,665 $3.79 Million | 37 |
Jan 29, 2025
Reduced 0.42%
|
|
Federico Grossi
Chief Medical Officer |
111,687 | 46,968 | 94,884 $2.8 Million | 56 |
Jan 05, 2023
Reduced 2.57%
|
|
Caroline Baumal
Chief Medical Officer |
100,588 | 7,420 | 93,301 $2.75 Million | 6 |
Jan 21, 2025
Added 29.79%
|
|
Mark Jeffrey De Long
Chief Business & Strat Officer |
151,961 | 82,146 | 84,308 $2.48 Million | 49 |
Jan 29, 2025
Reduced 0.43%
|
|
Adam J. Townsend
Chief Commercial Officer |
289,048 | 237,650 | 84,050 $2.48 Million | 49 |
Jan 29, 2025
Reduced 0.82%
|
|
Nur Nicholson
Chief Technical Officer |
133,545 | 52,340 | 83,664 $2.47 Million | 21 |
Jan 29, 2025
Reduced 0.98%
|
|
Karen Lewis
Chief People Officer |
105,449 | 36,094 | 70,251 $2.07 Million | 28 |
Jan 29, 2025
Reduced 0.52%
|
|
Lukas Scheibler
Chief Research Officer |
124,724 | 71,506 | 68,299 $2.01 Million | 30 |
Dec 01, 2023
Reduced 12.77%
|
|
Jeffrey Eisele
Chief Development Officer |
85,486 | 30,174 | 55,312 $1.63 Million | 29 |
Jan 29, 2025
Reduced 0.5%
|
|
James George Chopas
VP/Chief Accounting Officer |
52,524 | 8,069 | 48,138 $1.42 Million | 22 |
Jan 22, 2025
Reduced 2.23%
|
|
Victoria L. Brown
Program Team Lead |
36,598 | 17,157 | 23,556 $694,195 | 14 |
Jan 20, 2023
Reduced 5.66%
|
|
Paul R. Fonteyne
Director |
17,705 | 0 | 22,705 $669,116 | 4 |
Jan 01, 2025
Added 21.63%
|
|
Gerald Chan
Director |
17,705 | 0 | 17,705 $521,766 | 4 |
Jan 01, 2025
Added 26.14%
|
|
Stephanie Monaghan O'Brien
Director |
17,705 | 0 | 17,705 $521,766 | 4 |
Jan 01, 2025
Added 26.14%
|
|
Keli Walbert
Director |
9,090 | 0 | 9,090 $267,882 | 1 |
Jan 08, 2025
Added 50.0%
|
|
Nicole D Perry
Vice President - Accounting |
32,500 | 30,153 | 4,847 $142,841 | 22 |
Aug 02, 2021
Reduced 17.1%
|